Amy Whitworth

Efficacy of lenalidomide in patients with chronic lymphocytic leukemia with high-risk cytogenetics

Taimur Sher, Kena C. Miller, David Lawrence et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2010 · 82 citations

Medicine, Oncology, Pharmacotherapy +13

Phase I Study of Rigosertib, an Inhibitor of the Phosphatidylinositol 3-Kinase and Polo-like Kinase 1 Pathways, Combined with Gemcitabine in Patients with Solid Tumors and Pancreatic Cancer

Wen Wee, Wells A. Messersmith, Grace K. Dy et al. · Clinical Cancer Research · 2012 · 54 citations

Medicine, Oncology, Pharmacology +16

A Phase Ib Study of the FGFR/VEGFR Inhibitor Dovitinib With Gemcitabine and Capecitabine in Advanced Solid Tumor and Pancreatic Cancer Patients

Wen Wee, Hao Xie, Gerald Fetterly et al. · American Journal of Clinical Oncology · 2018 · 33 citations · Full text

Medicine, Oncology, Pharmacology +17

<i>RAPID COMMUNICATION</i>: A COMPARISON OF FREE T4 AND THE RATIO OF TOTAL T4 TO T4‐BINDING GLOBULIN IN SERUM THROUGH PREGNANCY

Amy Whitworth, J.E.M. Midgley, T A Wilkins · Clinical Endocrinology · 1982 · 27 citations

Medicine, Endocrinology, Obstetrics +12

Quality-of-Life (QOL) during Screening for Phase 1 Trial Studies in Patients with Advanced Solid Tumors and Its Impact on Risk for Serious Adverse Events

Sidra Anwar, Wei Tan, Chi-Chen Hong et al. · Cancers · 2017 · 11 citations · Full text

Pharmacy, Oncology, Good Clinical Practice +14